Erik Emerson is the founder of Apimeds Pharmaceuticals. Apimeds Pharmaceuticals has raised $100M in total funding. Latest round: Growth.
Erik Emerson served as the Chief Executive Officer at Apimeds Pharmaceuticals US, Inc., a clinical-stage biopharmaceutical company. He was removed from the board of directors of Apimeds Pharmaceuticals and is currently the CEO of Lokahi Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide